文献速递结核与非结核分枝杆菌

Cepheid三基因宿主反应指尖血试验诊断结核的前瞻性多中心研究中期结果

Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results.
PubMed 文献 · Clin Infect Dis · 2022-01-01

该前瞻性多中心研究在南非、冈比亚、乌干达和越南纳入有结核症状的成人,评估Cepheid Xpert MTB Host Response(MTB-HR)原型指尖血试验的诊断准确性。以GeneXpert Ultra为参考时,TB评分区分结核与其他呼吸疾病的AUC为0.94,敏感性87%、特异性94%;以复合微生物学评分为参考时AUC为0.88,敏感性80%、特异性94%。结果不受HIV状态或地理位置影响。

要点

  • MTB-HR指尖血试验对结核与其他呼吸疾病区分度好,AUC达0.94。
  • 以复合微生物学评分为参考时敏感性80%、特异性94%。
  • 诊断准确性不受HIV感染状态或地理位置影响。

核心结论

  • Cepheid MTB-HR指尖血试验达到结核即时分诊试验的最低目标产品特征,且不受地理区域或HIV感染状态影响。

研究设计与样本

  • 前瞻性多中心研究,在南非、冈比亚、乌干达和越南纳入有结核症状的成人,分析指尖血MTB-HR原型。
  • 以GeneXpert Ultra结果及GeneXpert Ultra联合液体培养的复合微生物学评分作为参考标准,将患者分为结核组与其他呼吸疾病组。

主要发现

  • 当分诊试验敏感性设定为90%时,特异性为86%(95%CI 75-97%)。
  • 结果不受HIV状态或地理位置影响。

临床怎么用

  • MTB-HR指尖血试验可作为结核即时分诊工具,用于有结核症状的成人,辅助区分结核与其他呼吸疾病。

局限性

  • 本文报告的是中期结果,样本量有限,最终结论需待完整研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The development of a fast and accurate, non-sputum-based point-of-care triage test for tuberculosis (TB) would have a major impact on combating the TB burden worldwide. A new fingerstick blood test has been developed by Cepheid (the Xpert MTB Host Response [MTB-HR] prototype), which generates a "TB score" based on messenger RNA (mRNA) expression of 3 genes. Here we describe the first prospective findings of the MTB-HR prototype. METHODS: Fingerstick blood from adults presenting with symptoms compatible with TB in South Africa, The Gambia, Uganda, and Vietnam was analyzed using the Cepheid GeneXpert MTB-HR prototype. Accuracy of the Xpert MTB-HR cartridge was determined in relation to GeneXpert Ultra results and a composite microbiological score (GeneXpert Ultra and liquid culture) with patients classified as having TB or other respiratory diseases (ORD). RESULTS: When data from all sites (n = 75 TB, 120 ORD) were analyzed, the TB score discriminated between TB and ORD with an area under the curve (AUC) of 0.94 (95% confidence interval [CI], .91-.97), sensitivity of 87% (95% CI, 77-93%) and specificity of 94% (88-97%). When sensitivity was set at 90% for a triage test, specificity was 86% (95% CI, 75-97%). These results were not influenced by human immunodeficiency virus (HIV) status or geographical location. When evaluated against a composite microbiological score (n = 80 TB, 111 ORD), the TB score was able to discriminate between TB and ORD with an AUC of 0.88 (95% CI, .83-.94), 80% sensitivity (95% CI, 76-85%) and 94% specificity (95% CI, 91-96%). CONCLUSIONS: Our interim data indicate the Cepheid MTB-HR cartridge reaches the minimal target product profile for a point of care triage test for TB using fingerstick blood, regardless of geographic area or HIV infection status.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sutherland JS, van der Spuy G, Gindeh A, et al. Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results. Clin Infect Dis. 2022. PMID: 34550342. doi:10.1093/cid/ciab839

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。